US Map / Florida
State FL

Clinical Trials in Florida

Florida is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Florida and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 565 actively recruiting studies with Florida sites out of 565 registered in total. The busiest research areas in Florida are Prostate Cancer, Breast Cancer, Ovarian Cancer. Leading sponsors running trials in the state include University of Florida, University of Miami, Mayo Clinic. By stage, Florida trials break down as Phase 1 (116), Phase 2 (175), Phase 3 (130), Phase 4 (21).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
565
Recruiting Now
565
← Back to US Map
Top Conditions in Florida
Prostate Cancer (15)Breast Cancer (13)Ovarian Cancer (11)Cancer (10)Colorectal Cancer (10)Schizophrenia (8)Advanced Solid Tumors (7)Obesity (7)Solid Tumor (6)Esophageal Cancer (6)Advanced Solid Tumor (6)Metastatic Breast Cancer (6)

Frequently Asked Questions — Clinical Trials in Florida

How many clinical trials are currently recruiting in Florida?
ClinicalMetric currently tracks 565 actively recruiting clinical trials with at least one location in Florida. The total number of registered studies—including active but not currently enrolling trials—is 565. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Florida?
Florida hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Breast Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Florida serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Florida?
To join a clinical trial in Florida, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Florida maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Florida

NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therap...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
473 pts
Location
United States, Australia, Canada
Sponsor
Bicara Therapeutics
View Trial →
NCT07694986 Phase 2
Recruiting
Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivol...
Condition
Breast Cancer
Enrollment
30 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
View Trial →
NCT06095505 Phase 2
Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Condition
Small Cell Lung Cancer
Enrollment
120 pts
Location
United States
Sponsor
Puma Biotechnology, Inc.
View Trial →
NCT05654922 Phase 3
Recruiting
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progress...
Condition
Pre-Bronchiolitis Obliterans Syndrome
Enrollment
100 pts
Location
United States
Sponsor
Renovion, Inc.
View Trial →
NCT07300969 Phase 2
Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Condition
Major Depressive Disorder (MDD)
Enrollment
300 pts
Location
United States, Bulgaria, Czechia
Sponsor
Draig Therapeutics Ltd
View Trial →
NCT06512727 N/A
Recruiting
The PROACTIVE Study for Black Elders
Condition
Musculoskeletal Pain
Enrollment
120 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT05489705 N/A
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treat...
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
1,700 pts
Location
United States, Austria, Czechia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05566769 N/A
Recruiting
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMO...
Condition
Neuromyelitis Optica
Enrollment
103 pts
Location
United States, France, Germany
Sponsor
Ad scientiam
View Trial →
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
View Trial →
NCT07527988 N/A
Recruiting
Safer Drinking Spaces Study
Condition
Sexual Violence
Enrollment
3,180 pts
Location
United States
Sponsor
RTI International
View Trial →
NCT04098146 N/A
Recruiting
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reco...
Condition
Mandibular Reconstruction
Enrollment
300 pts
Location
United States, Germany, Japan
Sponsor
AO Innovation Translation Cent
View Trial →
NCT06742996 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib ...
Condition
Mantle Cell Lymphoma
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
BeOne Medicines
View Trial →
NCT07361562 Phase 1
Recruiting
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Soli...
Condition
Advanced Solid Tumor, Adult
Enrollment
100 pts
Location
United States
Sponsor
Cogent Biosciences, Inc.
View Trial →
NCT06606210 N/A
Recruiting
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Car...
Condition
Wound Heal
Enrollment
120 pts
Location
United States
Sponsor
ConvaTec Inc.
View Trial →
NCT05893888 Phase 2, Phase 3
Recruiting
A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subj...
Condition
Oral Squamous Cell Carcinoma
Enrollment
40 pts
Location
United States
Sponsor
Privo Technologies
View Trial →
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT06022029 Phase 1
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in ...
Condition
Triple Negative Breast Cancer
Enrollment
168 pts
Location
United States, Australia
Sponsor
OncoNano Medicine, Inc.
View Trial →
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately ...
Condition
Ulcerative Colitis
Enrollment
252 pts
Location
United States, Austria, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT06997081 Phase 2
Recruiting
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma (ADVANCE 2.0)
Condition
Multiple Myeloma
Enrollment
104 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT05757219 Phase 2
Recruiting
Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
Condition
Diffuse Large B Cell Lymphoma
Enrollment
27 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
View Trial →
NCT00477100 N/A
Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Ti...
Condition
Inflammatory Breast Carcinoma
Enrollment
1,200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Australia, Belgium
Sponsor
Kura Oncology, Inc.
View Trial →
NCT05581030 Phase 1
Recruiting
CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Condition
Acute Lymphoblastic Leukemia
Enrollment
7 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
View Trial →
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
View Trial →
Page 3 of 23 — 565 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology